Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2022-01-27 00:00:00 ET · period of report 2022-01-26 · accession 0001209191-22-005222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-27 | 2022-01-26 | CRBU | Haurwitz Rachel E. | Pres, CEO, Dir | M - OptEx | $2.96 | +10.0K | 3.36M | +0.3% | +$29.6K |
| D | 2022-01-27 | 2022-01-26 | CRBU | Haurwitz Rachel E. | Pres, CEO, Dir | M - OptEx | $0.00 | -10.0K | 126.3K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-26 | M | A | 10,000 | $2.96 | 3,359,395 | D | — | — | |
| 2 | Derivative | Option to purchase Common Stock | 2022-01-26 | M | D | 10,000 | $0.00 | 126,350 | D | $2.96 · — to 2023-06-11 | 10,000 Common Stock | (F1) Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.95 per share on the reporting person's Form 3 filed on July 22, 2021. (F2) 1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on June 12, 2022, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. |